• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泼尼松龙与苯丁酸氮芥联合治疗伴进行性肾衰竭的特发性膜性肾病

Prednisolone and chlorambucil therapy for idiopathic membranous nephropathy with progressive renal failure.

作者信息

Warwick G L, Geddes C G, Boulton-Jones J M

机构信息

Renal Unit, Royal Infirmary, Glasgow, UK.

出版信息

Q J Med. 1994 Apr;87(4):223-9.

PMID:8208913
Abstract

Twenty-one patients with membranous nephropathy, heavy proteinuria and progressive renal failure were treated with alternating monthly cycles of corticosteroids and chlorambucil for six months. Four patients received repeat courses. After a median period of follow-up of 39 months, three patients had died, six were receiving renal replacement therapy or had serum creatinine > 500 mumol/l, and one had progressive renal failure. Eleven patients had either stable or improved renal function, as judged by serum creatinine concentration. Of these eleven, four patients were in partial remission (daily protein excretion 0.2-2.0 g), and two were in complete remission. There was a tendency for those who received intravenous methylprednisolone to have a more favourable outcome. There was a high incidence of side-effects, with significant complications related to drug therapy observed in > 50% of subjects. Although individual patients appeared to respond well, sometimes dramatically, these results are less encouraging than other reports. We would urge caution in the use of this form of therapy, particularly in older patients who may have occult neoplasms, impaired glucose intolerance or pre-existing cardiac disease.

摘要

21例膜性肾病伴大量蛋白尿和进行性肾衰竭患者接受了皮质类固醇和苯丁酸氮芥交替治疗,每月为一个周期,共治疗6个月。4例患者接受了重复疗程。在中位随访期39个月后,3例患者死亡,6例正在接受肾脏替代治疗或血清肌酐>500μmol/L,1例出现进行性肾衰竭。根据血清肌酐浓度判断,11例患者肾功能稳定或改善。在这11例患者中,4例部分缓解(每日蛋白尿排泄量0.2 - 2.0g),2例完全缓解。接受静脉注射甲泼尼龙的患者预后似乎更好。副作用发生率较高,超过50%的受试者出现了与药物治疗相关的严重并发症。尽管个别患者反应良好,有时甚至非常显著,但这些结果并不比其他报告更令人鼓舞。我们强烈建议谨慎使用这种治疗方式,尤其是在可能患有隐匿性肿瘤、糖耐量受损或已有心脏病的老年患者中。

相似文献

1
Prednisolone and chlorambucil therapy for idiopathic membranous nephropathy with progressive renal failure.泼尼松龙与苯丁酸氮芥联合治疗伴进行性肾衰竭的特发性膜性肾病
Q J Med. 1994 Apr;87(4):223-9.
2
A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.甲基泼尼松龙与苯丁酸氮芥治疗特发性膜性肾病的随机试验。
N Engl J Med. 1989 Jan 5;320(1):8-13. doi: 10.1056/NEJM198901053200102.
3
Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.泼尼松龙与硫唑嘌呤治疗膜性肾病:一项10年随访研究
Clin Nephrol. 2006 May;65(5):317-23.
4
Treatment and long-term follow-up of patients with stage II to III idiopathic membranous nephropathy.II至III期特发性膜性肾病患者的治疗及长期随访
Am J Kidney Dis. 1999 Nov;34(5):911-7. doi: 10.1016/S0272-6386(99)70050-8.
5
Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.膜性肾病和肾功能不全的细胞毒性治疗:改善肾脏存活率但复发率高。
Nephrol Dial Transplant. 2004 May;19(5):1142-8. doi: 10.1093/ndt/gfh036. Epub 2004 Feb 19.
6
Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.低剂量苯丁酸氮芥治疗特发性膜性肾病肾病患者的疗效与安全性
Kidney Blood Press Res. 2009;32(4):263-7. doi: 10.1159/000239539. Epub 2009 Sep 21.
7
The therapy of idiopathic membranous glomerulonephritis.特发性膜性肾小球肾炎的治疗
Semin Nephrol. 1991 Mar;11(2):138-47.
8
Idiopathic membranous nephropathy in the elderly.老年人特发性膜性肾病
Nephrol Dial Transplant. 1993;8(12):1321-5.
9
Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.口服环磷酰胺和类固醇对膜性肾病伴肾功能不全患者的短期和长期疗效。研究组
Clin Nephrol. 2001 Jul;56(1):1-9.
10
Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group.甲基强的松龙联合苯丁酸氮芥与单独使用甲基强的松龙治疗特发性膜性肾病的比较。意大利特发性膜性肾病治疗研究组。
N Engl J Med. 1992 Aug 27;327(9):599-603. doi: 10.1056/NEJM199208273270904.

引用本文的文献

1
Chapter 7: Idiopathic membranous nephropathy.第7章:特发性膜性肾病。
Kidney Int Suppl (2011). 2012 Jun;2(2):186-197. doi: 10.1038/kisup.2012.20.
2
Idiopathic membranous nephropathy: management strategies.特发性膜性肾病:治疗策略
Drugs. 2009 Jul 9;69(10):1303-17. doi: 10.2165/00003495-200969100-00002.
3
Characteristics and outcome of membranous nephropathy in older patients.老年患者膜性肾病的特征与转归
Int Urol Nephrol. 2002;33(1):157-65. doi: 10.1023/a:1014404006045.